| Cas No.: | 841205-47-8 |
| Chemical Name: | Ostarine |
| Synonyms: | (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide;Ostarine;(S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropionamide;MK-2866;MK-2866 (GTx-024);MK-2866 (Ostarine);Ostarine NOT FOR SAL;Ostarine NOT FOR SALE-PATENTED;OSTARINE(MK-2866);MK2866;Enobosarm;Enobosarmum;(2S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide (ACI);GTx 024;MK 2866;SARM S-22;V 024;V-024 |
| SMILES: | C(C1C=C(NC(=O)[C@](O)(C)COC2C=CC(C#N)=CC=2)C=CC=1C#N)(F)(F)F |
| Formula: | C19H14F3N3O3 |
| M.Wt: | 389.327974796295 |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | Ostarine(MK-2866; GTX-024) is a modulator of human androgen receptor.IC50 value:Target: androgen receptorOstarine (MK-2866) is an androgen receptor modulator (SARM) with an ED50 of 0.44 mg/day. Ostarine (MK-2866) has anabolic activity. Lack of PSA increases in men and hair growth in women further corroborated selective anabolic effects of Ostarine (MK-2866). Ostarine (MK-2866) also resulted in a dose-dependent decrease in LDL and HDL cholesterol levels, with the average LDL/HDL ratio for all doses remaining in the low cardiovascular risk catergory. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
